New long-term opioid use associated with increased risk for two-year all-cause mortality, especially for potent opioid use

Reduced segmentation time, interobserver variability seen with artificial intelligence assistance in segmentation for radiotherapy targeting

About 15 percent of patients diagnosed with lung cancer had PGVs, most of which were potentially clinically actionable

Drug approved for non-small cell lung cancer with mutation leading to MET exon 14 skipping

Little or no interest in sexual activity reported by majority of patients surveyed

Risk for incident lung cancer increased for current smokers and former smokers not recommended for annual low-dose CT screening

Only 29 percent of Americans know that lung cancer is the No. 1 cancer killer

Sociodemographic disparities may make successful telemedicine visits less likely, leading to increased chances for poorer outcomes

Expanding lung cancer screening criteria is step toward greater equity for high-risk populations

Findings persist among race/ethnic groups, regardless of government or private insurance, and across facility types